Intramuscular Testosterone Therapy Tied With Rise in Hematocrit
The risk of hematocrit elevation may depend on testosterone therapy’s route of administration, according to investigators.
The risk of hematocrit elevation may depend on testosterone therapy’s route of administration, according to investigators.
A recent study found a racial disparity in the use of guideline-concordant treatment for metastatic prostate cancer.
Increased risk of intracranial tumors, leukemia, and lymphoma by age 25 seen with exposure to 4 or more CT scans during childhood
Results are from a meta-analysis of 33 trials involving 35,939 patients with overactive bladder.
Compared with White patients, Black patients have 71% higher odds of cardiotoxicity
Kidney function was not harmed over 52 weeks of pegloticase and methotrexate co-therapy in patients with uncontrolled gout at baseline.
Patients with persistent ESA hyporesponse had especially high rates of adverse events.
Kidney transplant recipients are at high risk for hyperuricemia due to multiple contributing factors.
The slow clinical adoption of sodium-glucose cotransporter-2 inhibitors may partly be due to concerns about potential adverse effects, investigators suggested.
While uncommon, BK polyomavirus-associated nephropathy is associated with a “substantial” risk of graft loss in kidney transplant recipients.